Cargando…

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease

Detalles Bibliográficos
Autores principales:	Roncati, Luca, Lusenti, Beatrice, Nasillo, Vincenzo, Manenti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245576/ https://www.ncbi.nlm.nih.gov/pubmed/32447425 http://dx.doi.org/10.1007/s00277-020-04098-z

Ejemplares similares

Signals of T(h)2 immune response from COVID-19 patients requiring intensive care
por: Roncati, Luca, et al.
Publicado: (2020)

High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a T(h)2 response due to severe COVID-19
por: Roncati, Luca, et al.
Publicado: (2020)

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19
por: Roncati, Luca, et al.
Publicado: (2021)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Type 3 hypersensitivity in COVID-19 vasculitis
por: Roncati, Luca, et al.
Publicado: (2020)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

The «moonlighting protein» able to explain the T(h)1 immune lockdown in severe COVID-19()
por: Roncati, Luca, et al.
Publicado: (2020)

Deepening Pathology of SARS-CoV-2 Pneumonia Explains Lung Ventilation Complications
por: Manenti, Antonio, et al.
Publicado: (2022)

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
por: Bacha, Dhouha, et al.
Publicado: (2017)

COVID-19 thromboembolic complications: Deepening immunoinflammatory features
por: Roncati, Luca, et al.
Publicado: (2021)

Toward a unified pathophysiology in COVID-19 acute aortopathies
por: Roncati, Luca, et al.
Publicado: (2021)

Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022)

Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2
por: Roncati, Luca, et al.
Publicado: (2020)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

Rates of Coinfection Between SARS-CoV-2 and Other Respiratory Viruses in Korea
por: Kim, Young-gon, et al.
Publicado: (2022)

Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?
por: Roncati, Luca, et al.
Publicado: (2021)

Nonpharmaceutical intervention is an effective measure to block respiratory virus coinfections with SARS-CoV-2
por: Ru, Xuanwen, et al.
Publicado: (2023)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
por: Finsterer, Josef, et al.
Publicado: (2021)

Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
por: Mazzola Poli de Figueiredo, Sergio, et al.
Publicado: (2022)

Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
por: Roncati, Luca, et al.
Publicado: (2021)

Fatal Guillain-Barre syndrome after infection with SARS-CoV-2()
por: Marta-Enguita, J., et al.
Publicado: (2020)

Neisseria meningitidis bacteraemia and SARS-CoV-2 infection: a coinfection that reminds previous epidemic outbreaks
por: Martín-Romero, Miguel, et al.
Publicado: (2022)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

Potentials of post-mortem CT (PMCT) in paediatric cases related to SARS-CoV-2 infection
por: Filograna, Laura, et al.
Publicado: (2023)

Fatal SARS-CoV-2 infection in a male patient with Good's syndrome
por: Pozzi, Maria Rosa, et al.
Publicado: (2021)

Undetermined Fatal Complications of SARS-CoV-2 Vaccinations Require Clarification by Autopsy
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?
por: Lugito, Nata Pratama Hardjo
Publicado: (2021)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease()()
por: Ordoñez-Parra, Juliana, et al.
Publicado: (2021)

Fatal familial hemophagocytic lymphohistiocytosis with perforin gene (PRF1) mutation and EBV-associated T-cell lymphoproliferative disorder of the thyroid
por: Mian, Agrima, et al.
Publicado: (2019)

Lymphoproliferative malignancies in patients with neurofibromatosis 1
por: Bergqvist, Christina, et al.
Publicado: (2021)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Fatal sepsis months after bladder instillations with Mycobacterium bovis in patient with SARS-CoV-2 infection
por: García-Ceberino, Pedro Manuel, et al.
Publicado: (2021)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6mae0flt7qqeld7f187892poph